CPMV (Mosaic ImmunoEngineering) Days Inventory: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mosaic ImmunoEngineering Days Inventory?

Mosaic ImmunoEngineering CPMV +11.11% Days Inventory is 0.00 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Mosaic ImmunoEngineering ranks worse than 156739.66% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Mosaic ImmunoEngineering's Average Total Inventories for the three months ended in Mar. 2026 was $0.00 Mil. Mosaic ImmunoEngineering's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Mosaic ImmunoEngineering's Days Inventory or its related term are showing as below:

CPMV's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 182.6
* Ranked among companies with meaningful Days Inventory only.

Mosaic ImmunoEngineering's Days Inventory stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Mosaic ImmunoEngineering  (OTCPK:CPMV) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Mosaic ImmunoEngineering's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Mosaic ImmunoEngineering's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Mosaic ImmunoEngineering Days Inventory Related Terms


Mosaic ImmunoEngineering Days Inventory Historical Data

* Premium members only.

The historical data trend for Mosaic ImmunoEngineering's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering Days Inventory Chart

Mosaic ImmunoEngineering Annual Data
Trend May16 May17 May18 May19 May20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mosaic ImmunoEngineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPMV vs TCRT, JAGX, BGMS: Days Inventory Comparison

For the Biotechnology subindustry, Mosaic ImmunoEngineering's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mosaic ImmunoEngineering Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's Days Inventory distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's Days Inventory falls into.



Mosaic ImmunoEngineering Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Mosaic ImmunoEngineering's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Mosaic ImmunoEngineering's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Mosaic ImmunoEngineering (CPMV) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mosaic ImmunoEngineering and its competitors. According to the industry distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 638 companies in the Biotechnology industry.
Is Mosaic ImmunoEngineering's Days Inventory too high?
Mosaic ImmunoEngineering's current Days Inventory is 0.00. Based on the distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Mosaic ImmunoEngineering's Days Inventory compare to TCRT and JAGX?
According to the Biotechnology industry distribution chart, Mosaic ImmunoEngineering ranks #999999 out of 638 companies for Days Inventory. This places Mosaic ImmunoEngineering in the lower half of its industry. The industry median Days Inventory is 182.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.60, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mosaic ImmunoEngineering and its competitors. For the Biotechnology industry, the median Days Inventory is 182.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mosaic ImmunoEngineering's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mosaic ImmunoEngineering stock overvalued right now?
Mosaic ImmunoEngineering (CPMV) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Mosaic ImmunoEngineering (CPMV), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mosaic ImmunoEngineering Business Description

Address 9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions. The company is pursuing new product candidates and platforms to build a product pipeline based on its deep understanding of immunotherapies.